Segnos
Segnos develops diagnostic technologies that use magnetic nanoparticles for highly sensitive biomarker detection.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredSep 5, 2024 (2 years old)
Funding rounds
- Seed · amount undisclosed
BBP Capital (lead),
JJNC Corporation
Source: thebridge.jp - Website created
Team
TO
Tokuyuki Onishi CEO and President
Investors
Similar Health and bio companies
BBasalt Health$20M Series A · Oct 2026
AAtlas Bio$12.5M Seed · Oct 2026CCent$15M Series A · Oct 2026
IImphatec$2M Seed · Oct 2026
Aadsilico$13.35M Series A · Oct 2026
CClinics On Cloud$12.61M Series A · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/segnos (get a free API key).